10-Q: Spectaire Holdings Inc. Reports First Quarter 2024 Results Amidst Going Concern Uncertainty

Sentiment:

Quarterly Report


Spectaire Holdings Inc. reported a net loss of $2.5 million for the first quarter of 2024 and expressed substantial doubt about its ability to continue as a going concern.

Capital raiseThe company intends to raise additional capital through equity raises.The company entered into a subscription agreement with an investor for $2 million.The company has the right, but not the obligation, to sell up to $20 million of newly issued shares of common stock to Keystone.
Worse than expectedThe company's financial results were worse than expected due to the lack of revenue, significant losses, and the going concern warning.

Summary

  • Spectaire Holdings Inc. reported a net loss of $2.5 million for the three months ended March 31, 2024, compared to a net loss of $4.4 million for the same period in 2023.
  • The company's operating loss for the quarter was $2.0 million, a decrease from $4.3 million in the prior year.
  • Spectaire's cash balance decreased to $31,414 as of March 31, 2024, from $342,996 at the end of 2023.
  • The company has a net working capital deficit of $27.9 million and an accumulated deficit of $29.7 million.
  • Management has expressed substantial doubt about the company's ability to continue as a going concern due to its liquidity condition.
  • The company's revenue was $0 for the quarter.
  • Research and development expenses increased to $945,125, up from $599,227 in the same period last year.
  • General and administrative expenses decreased significantly to $919,796 from $3,611,677 in the prior year period.
  • Interest expense increased dramatically to $2.4 million, primarily due to the Arosa loan and related warrants.
  • The company recognized a gain of $515,750 from changes in the fair value of forward purchase agreements and a gain of $1,353,000 from changes in the fair value of earnout liabilities.

Sentiment

Score: 2

Explanation: The document indicates a very negative sentiment due to the company's low cash balance, significant losses, going concern warning, and lack of revenue. The company's future is highly uncertain.

Positives

  • The net loss decreased by $1.85 million compared to the same quarter last year.
  • General and administrative expenses decreased by $2.7 million compared to the same quarter last year.
  • The company recognized a gain of $515,750 from changes in the fair value of forward purchase agreements.
  • The company recognized a gain of $1,353,000 from changes in the fair value of earnout liabilities.

Negatives

  • The company's cash balance is critically low at $31,414.
  • Spectaire has a significant net working capital deficit of $27.9 million.
  • Management has raised substantial doubt about the company's ability to continue as a going concern.
  • There was no revenue for the quarter.
  • Interest expenses surged to $2.4 million due to the Arosa loan and related warrants.

Risks

  • The company's low cash balance and significant working capital deficit raise concerns about its ability to fund operations.
  • The going concern warning indicates a high risk of potential business failure.
  • The company is dependent on raising additional capital, which may not be available on acceptable terms or at all.
  • The company has a high level of debt, including the Arosa loan, which is accruing interest at 20% per annum.
  • The company is dependent on a small number of customers for a substantial portion of its future revenue.
  • The company's stock price is below $1, which could lead to delisting from the Nasdaq.

Future Outlook

The company's future capital requirements will depend on many factors, including the company's revenue growth rate, the timing and extent of spending to support further sales and marketing, and research and development efforts. The company intends to raise additional capital through equity raises, but there is no assurance that it will be able to do so on acceptable terms or at all.

Management Comments

  • Management has determined that the company's liquidity condition raises substantial doubt about the company's ability to continue as a going concern through twelve months from the date these condensed consolidated financial statements are available to be issued.
  • Management intends to implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting.

Industry Context

The company operates in the industrial technology sector, focusing on emissions measurement and management. The increasing pressure on companies to reduce emissions creates a potential market for Spectaire's technology. However, the company faces competition from other emissions monitoring solutions and must demonstrate the value and accuracy of its AireCore technology.

Comparison to Industry Standards

  • It is difficult to compare Spectaire's results directly to industry standards due to its early stage and unique technology.
  • Many companies in the emissions monitoring space are larger and more established, with significant revenue streams.
  • Spectaire's lack of revenue and significant losses are not typical for established companies in the sector.
  • The company's going concern warning is a significant deviation from industry norms, indicating a high level of financial distress.
  • The company's reliance on debt financing and equity raises is also not typical for established companies in the sector.

Related Party Transactions

  • The Chief Executive Officer and Chief Information Officer of Spectaire jointly own and are employed by an entity providing staffing services to Spectaire.
  • Certain related parties have entered into convertible notes with the company.
  • The company entered into a joint venture agreement with Spectaire Europe GmbH, an affiliate of a director of the company.

Stakeholder Impact

  • Shareholders face significant risk due to the company's financial distress and going concern warning.
  • Employees face uncertainty about the company's future and their job security.
  • Customers may be hesitant to engage with the company due to its financial instability.
  • Suppliers and creditors face increased risk of non-payment.

Next Steps

  • The company intends to raise additional capital through equity raises.
  • The company intends to implement remediation steps to improve its disclosure controls and procedures and its internal control over financial reporting.
  • The company will actively monitor the closing bid price for its common stock and will consider available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement.

Key Dates

DateDescription
2022-10-31PCCT issued a convertible promissory note to its sponsor for up to $720,000.
2023-01-16Spectaire entered into a merger agreement with Perception Capital Corp. II (PCCT).
2023-03-31Spectaire entered into the Arosa Loan Agreement for up to $6.5 million.
2023-04-10PCCT amended the debt, increasing the aggregate principal amount of the Extension Loan up to $1,200,000.
2023-04-17Funds held in escrow under the Arosa Loan Agreement were released.
2023-05-02The company issued Arosa the Closing Date Warrant to purchase 2,200,543 shares of common stock.
2023-06-30Spectaire entered into an agreement with a vendor for the co-build of 5 AireCore Mass Spectrometers.
2023-10-04The company entered into a subscription agreement with an investor for $650,000.
2023-10-11The company entered into a private placement subscription agreement with an investor for $3.5 million.
2023-10-13The Company requested an additional advance of $650,000 under the Arosa Loan Agreement.
2023-10-16The company effected a deregistration under the Companies Act (As Revised) of the Cayman Islands and a domestication under the General Corporation Law of the State of Delaware.
2023-10-17PCCT amended the debt, extending the maturity date to 180 days following the consummation of the Business Combination.
2023-10-19The Business Combination with PCCT closed, and the company issued an additional warrant to Arosa.
2023-11-17The company entered into a common stock purchase agreement with Keystone and a convertible note with an investor.
2023-12-14The company entered into a further agreement with a vendor for a co-build of 30 additional spectrometers.
2023-12-22The company entered into a joint venture agreement with MLab Capital GmbH and Spectaire Europe GmbH.
2024-03-18The company entered into a subscription agreement with an investor for $2 million.
2024-03-27The Arosa Loan and the Additional Advance matured.
2024-04-05The company entered into an amended loan agreement with Arosa.
2024-04-14The company amended and restated the Working Capital Loans.
2024-04-23The company amended and restated the Working Capital Loans.
2024-05-15The date of the quarterly report.

Keywords

Spectaire, financial results, going concern, net loss, cash balance, working capital, Arosa loan, debt, emissions, AireCore, mass spectrometer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.